Additional mammogram readers improve breast cancer detectionJuly 25, 2007Mammogram readings by both radiologists and non-physician technologists improve breast cancer detection rates, according to a study in the July 24 Journal of the National Cancer Institute. Studies have shown that breast cancer detection may increase when mammograms are reviewed by both a radiologist and a mammographic technologist. In The Netherlands, a breast cancer screening program was implemented in the 1990s that required all mammograms be read by two radiologists. Mammographic technologists were also trained to look for abnormalities. Lucien Duijm, M.D., Ph.D., of Catharina Hospital in Eindhoven, The Netherlands, and colleagues examined whether adding readings by two technologists to the standard examination by two radiologists would improve cancer detection rates and the accuracy of the readings. The breast cancer detection rate increased 6.8% (from 5.27 to 5.63 cancers per 1,000 women screened) when the mammograms were read by two technologists and two radiologists. And adding two technologists only slightly increased the number of false positives, compared with readings by a pair of radiologists alone. "Our results indicate that all technologist-positive readings should be considered for [further] examination because this subset of screening mammograms shows a high prevalence of breast cancer," the authors write. In an accompanying editorial, Joann Elmore, M.D., of Harborview Medical Center in Seattle and James Brenner, M.D., J.D., of the University of California, San Francisco discuss the challenges of generalizing the results of the study because of differences in screening programs around the world. "Ultimately, deciding on the number of readers needed to interpret a screening mammogram will depend on how many readers are available and which outcomes we seek," the authors write. Journal of the National Cancer Institute |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||